Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study

Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros

Source: ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020
Journal Issue: October
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vasilios Tzilas, Argyris Tzouvelekis, Evangelos Bouros, Theodoros Karampitsakos, Maria Ntassiou, Eleni Avdoula, Athena Trachalaki, Katerina Antoniou, Ganesh Raghu, Demosthenes Bouros. Clinical experience with antifibrotics in fibrotic hypersensitivity pneumonitis: a 3-year real-life observational study. ERJ Open Res, 6 (4) 00152-2020; 10.1183/23120541.00152-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of antifibrotics in chronic hypersensitivity pneumonitis. A 3 year real-life observational study
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


Late Breaking Abstract - 1-year radiological, functional and quality-of-life outcomes in patients with SARS-CoV-2 pneumonia: A prospective observational study.
Source: Virtual Congress 2021 – Respiratory infections
Year: 2021



Clinical, radiological and functional outcomes in patients with COVID-19 pneumonia: A prospective observational study
Source: Virtual Congress 2021 – Imaging in COVID-19
Year: 2021


A single-center observational study assessing response to mepolizumab in severe eosinophilic asthma
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019

PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients
Source: International Congress 2016 – IPF clinical
Year: 2016

Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

Feasibility of home spirometry in patients with chronic graft-versus-host disease: a prospective observational study
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020


Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study
Source: ERJ Open Res, 6 (1) 00172-2019; 10.1183/23120541.00172-2019
Year: 2020



Psychiatric complications of COVID-19 pneumonia: preliminary results of a single-centre prospective study.
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


Single-center prospective study on clinical evolution of non-specific pleuritis
Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Year: 2018


Late Breaking Abstract - 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation: A multicenter, single blinded, superiority RCT
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



COVID-19 pneumonia and clinical follow-up: results of a prospective cohort
Source: Virtual Congress 2021 – COVID - 19 risk predictions
Year: 2021


Late Breaking Abstract - IPF symptoms’ course during a 3-month observation: FIBRONET observational study’s preliminary results.
Source: International Congress 2017 – Miscellaneous clinical problems
Year: 2017


Efficacy and safety of sequential three-step empirical therapy for chronic cough: a multi-center clinical study
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017

A retrospective observational study to characterize severe eosinophilic asthma in Taiwan
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




PROOF-registry: A prospective observational registry to describe the disease course and outcomes of IPF patients in a real-world clinical setting- An interim report
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Chronic cough in routine clinical practice: a UK retrospective cohort study
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020

Clinical and inflammatory characteristics of patients with COPD in primary care: an observational study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Biomarker measurement in asthma patients receiving biologic therapy: a real-world retrospective study
Source: International Congress 2018 – Eosinophils in airway disease
Year: 2018